DOJ, US Atty Subpoena GSK Over Avandia, HIV Drugs

Law360, New York (October 21, 2010, 1:57 PM EDT) -- British drugmaker GlaxoSmithKline PLC disclosed Thursday that it was responding to federal subpoenas regarding its diabetes drug Avandia and three HIV products and that Foreign Corrupt Practices Act investigators had asked the company for information about its overseas activities.

GSK made the disclosures alongside an announcement detailing its third-quarter earnings. The company said the subpoenas sought information regarding the development and marketing of Avandia and the marketing and sales of the HIV products, which were not identified.

The company also said it believed the information requests...
To view the full article, register now.